Augmentation Equity

Definition

Augmentation Equity examines fair access, distribution of benefit and prevention of new capability-based disadvantage within the broader domain of therapeutic, assistive and elective technologies that extend cognitive, sensory or motor capability.

Why this matters

Failures concerning fair access, distribution of benefit and prevention of new capability-based disadvantage can cause physical or psychological harm, loss of function, privacy invasion, identity compromise, exclusion, coercion or irreversible impact on human agency.

Research questions

Under which conditions can fair access, distribution of benefit and prevention of new capability-based disadvantage be delivered, measured or protected reliably, and how do outcomes vary by person, device, duration, context and governance controls?

Hypotheses

A transparent, safety-bounded and person-centred approach to augmentation equity, combining validated measurement, informed consent, privacy and security controls, human oversight and longitudinal monitoring, will improve benefit–risk outcomes compared with opaque or technology-centred approaches.

Proposed methods

controlled performance testing; longitudinal outcome measurement; human-factors evaluation; equity analysis; dependency assessment; user interviews; ethics and policy review; expert and affected-user review; reproducibility testing; methods adapted specifically to Augmentation Equity

Stakeholders and beneficiaries

augmentation users; patients; clinicians; therapists; employers; insurers; manufacturers; disability advocates; regulators; carers